Related Experiment Videos

The National Cancer Institute's Natural Products Antineoplastic Development Program

J Douros, M Suffness

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer

|January 1, 1980

Abstract:

The present Natural Products Antineoplastic Development Program of the National Cancer Institute is reviewed, and the potential new anticancer agents being developed in each of the three natural products programs, fermentation, plant, and animal, are discussed [2, 5].

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Antitumor agents. 163. Three-dimensional quantitative structure-activity relationship study of 4'-O-demethylepipodophyllotoxin analogs using the modified CoMFA/q2-GRS approach.

Journal of medicinal chemistry·1996

Is taxol a surrogate for a universal regulator of mitosis?

In vivo (Athens, Greece)·1994

Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.

Cancer research·1994

The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents.

Journal of natural products·1993

A reassessment of cardiac toxicity associated with Taxol.

Journal of the National Cancer Institute. Monographs·1993

Clinical development of Taxol.

Journal of the National Cancer Institute. Monographs·1993

See all related articles